Biosensors International Wins FDA Approval For Drug-Eluting Coronary Stent
Executive Summary
The US agency’s Center for Devices and Radiological Health has granted a PMA to Biosensors International USA for its BioFreedom drug-eluting coronary stent System to treat coronary artery disease.